Oncolytics Biotech
ONCY
#9231
Rank
$0.10 B
Marketcap
$0.98
Share price
-0.84%
Change (1 day)
11.80%
Change (1 year)

Oncolytics Biotech (ONCY) - Cash on Hand

Cash on Hand as of September 2025 : $8.87 Million USD

According to Oncolytics Biotech 's latest financial reports the company has $8.87 Million USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Oncolytics Biotech - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$11.1 M-57.79%
2023-12-31$26.32 M11.14%
2022-12-31$23.68 M-26.85%
2021-12-31$32.37 M32.23%
2020-12-31$24.48 M126.03%
2019-12-31$10.83 M7.71%
2018-12-31$10.05 M6.83%
2017-12-31$9.41 M-10.42%
2016-12-31$10.5 M-44.09%
2015-12-31$18.79 M34.79%
2014-12-31$13.94 M-45.46%
2013-12-31$25.57 M19.43%
2012-12-31$21.41 M-37.51%
2011-12-31$34.26 M-20.17%
2010-12-31$42.92 M32.33%
2009-12-31$32.43 M197.06%
2008-12-31$10.91 M-56.8%
2007-12-31$25.27 M6.57%
2006-12-31$23.71 M-31.66%
2005-12-31$34.7 M22.9%
2004-12-31$28.24 M76.52%
2003-12-31$15.99 M203.72%
2002-12-31$5.26 M-43.95%
2001-12-31$9.39 M-20.09%
2000-12-31$11.76 M272.85%
1999-12-31$3.15 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Aeterna Zentaris
AEZS
$27.8 M 213.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$9.91 B 111,647.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$16.50 B 185,914.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$2.20 B 24,732.80%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
$77.39 M 772.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
$0.97 B 10,906.62%๐Ÿ‡บ๐Ÿ‡ธ USA